Pharvaris Nv (PHVS)

08:21 AM

Pharvaris FY2026 EPS Estimate Reduced by Leerink Partnrs - MarketBeat

08:21 AM

Jan 21, 2025

Pharvaris (NASDAQ:PHVS) Shares Up 5.3%Here's Why - MarketBeat

Jan 21, 2025

Jan 17, 2025

How To Trade (PHVS) - Stock Traders Daily

Jan 17, 2025

Jan 13, 2025

Pharvaris (NASDAQ:PHVS) Stock Price Down 11.7%Here's Why - MarketBeat

Jan 13, 2025

Jan 13, 2025

Pharvaris Advances Phase 3 HAE Programs, Expands Pipeline Into Acquired Angioedema Treatment - StockTitan

Jan 13, 2025

Jan 12, 2025

Geode Capital Management LLC Boosts Holdings in Pharvaris (NASDAQ:PHVS) - Defense World

Jan 12, 2025

Jan 09, 2025

Barclays PLC Takes Position in Pharvaris (NASDAQ:PHVS) - Defense World

Jan 09, 2025

Jan 06, 2025

(PHVS) Long Term Investment Analysis - Stock Traders Daily

Jan 06, 2025

Jan 06, 2025

Jane Street Group LLC Makes New Investment in Pharvaris (NASDAQ:PHVS) - Defense World

Jan 06, 2025

Jan 06, 2025

Jane Street Group LLC Acquires Shares of 28,418 Pharvaris (NASDAQ:PHVS) - MarketBeat

Jan 06, 2025

Jan 03, 2025

Pharvaris (NASDAQ:PHVS) Sees Unusually-High Trading VolumeHere's Why - MarketBeat

Jan 03, 2025

Jan 03, 2025

State Street Corp Purchases New Shares in Pharvaris (NASDAQ:PHVS) - Defense World

Jan 03, 2025

Jan 03, 2025

53,980 Shares in Pharvaris (NASDAQ:PHVS) Bought by State Street Corp - MarketBeat

Jan 03, 2025

Dec 31, 2024

Pharvaris (NASDAQ:PHVS) Trading Down 3.5%Here's Why - MarketBeat

Dec 31, 2024

Dec 29, 2024

Pharvaris: Despite 30% Decline, Still Fair At Best (NASDAQ:PHVS) - Seeking Alpha

Dec 29, 2024

Dec 28, 2024

Pharvaris (NASDAQ:PHVS) Sees Large Decrease in Short Interest - MarketBeat

Dec 28, 2024

Dec 27, 2024

Trend Tracker for (PHVS) - Stock Traders Daily

Dec 27, 2024

Dec 20, 2024

Pharvaris (PHVS) Shares Cross Above 200 DMA - Nasdaq

Dec 20, 2024

Dec 20, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Invests $906,000 in Pharvaris (NASDAQ:PHVS) - Defense World

Dec 20, 2024

Dec 20, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Makes New $906,000 Investment in Pharvaris (NASDAQ:PHVS) - MarketBeat

Dec 20, 2024

Dec 16, 2024

Learn to Evaluate (PHVS) using the Charts - Stock Traders Daily

Dec 16, 2024

Dec 14, 2024

Pharvaris (PHVS) Price Target Increased by 38.65% to 32.93 - MSN

Dec 14, 2024

Dec 06, 2024

Pharvaris price target lowered to $46 from $50 at JMP Securities - Yahoo Finance

Dec 06, 2024

Dec 05, 2024

Long Term Trading Analysis for (PHVS) - Stock Traders Daily

Dec 05, 2024

Nov 25, 2024

Pharvaris Reports Q3 2024 Progress and Financials - TipRanks

Nov 25, 2024

Nov 13, 2024

Pharvaris Reports 93% HAE Attack Reduction in Trial Data, Plans Phase 3 Study | PHVS Stock News - StockTitan

Nov 13, 2024

Nov 12, 2024

Pharvaris to Present HAE Treatment Progress at Guggenheim Healthcare Conference | PHVS Stock News - StockTitan

Nov 12, 2024

Nov 11, 2024

PHVS Makes Notable Cross Below Critical Moving Average - Nasdaq

Nov 11, 2024

Oct 30, 2024

Axonis Therapeutics Announces $115 Million Series A Financing - Financial Times

Oct 30, 2024

Oct 24, 2024

Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific Meeting - StockTitan

Oct 24, 2024

Oct 23, 2024

(PHVS) Proactive Strategies - Stock Traders Daily

Oct 23, 2024

Oct 16, 2024

PHVSPharvaris N.V. Ordinary Shares Latest Stock News & Market Updates - StockTitan

Oct 16, 2024

Oct 16, 2024

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at ... - The Hastings Tribune

Oct 16, 2024

Oct 16, 2024

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific Meetings - StockTitan

Oct 16, 2024

Oct 15, 2024

Pharvaris to Host Virtual Investor Event on October 23, 2024 - StockTitan

Oct 15, 2024

Oct 13, 2024

(PHVS) Investment Report - Stock Traders Daily

Oct 13, 2024

Oct 09, 2024

Pharvaris (NASDAQ:PHVS) Sees Strong Trading VolumeWhat's Next? - MarketBeat

Oct 09, 2024

Oct 04, 2024

Pharvaris (NASDAQ:PHVS) Shares Gap DownShould You Sell? - MarketBeat

Oct 04, 2024

Oct 03, 2024

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at - The Bakersfield Californian

Oct 03, 2024

Oct 03, 2024

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop - StockTitan

Oct 03, 2024

Sep 30, 2024

Novo Holdings A S Buys 556,970 Shares of Pharvaris (NASDAQ:PHVS) - MarketBeat

Sep 30, 2024

Sep 30, 2024

Pharvaris N.V.'s SWOT analysis: promising HAE drug boosts stock outlook - Investing.com India

Sep 30, 2024

Sep 25, 2024

Pharvaris CBO Resigns, Team Absorbs Duties - TipRanks

Sep 25, 2024

Sep 21, 2024

(PHVS) Technical Data - Stock Traders Daily

Sep 21, 2024

Sep 20, 2024

Hereditary Angioedema Therapeutics Global Market Report Explores 2024: Size Forecast and Growth Prospects 2033 - WhaTech

Sep 20, 2024

Sep 20, 2024

Pharvaris (NASDAQ:PHVS) Shares Gap Down to $21.09 - MarketBeat

Sep 20, 2024

Sep 20, 2024

EQS-Adhoc: BRAIN Biotech AG concludes royalty monetization deal for up to EUR 128.88 million on investigational pharma compound deucrictibant with Royalty Pharma - sharewise

Sep 20, 2024

Sep 19, 2024

Pharvaris (NASDAQ:PHVS) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Sep 19, 2024